These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22580115)

  • 1. Enhanced targeted anticancer effects and inhibition of tumor metastasis by the TMTP1 compound peptide TMTP1-TAT-NBD.
    Liu R; Xi L; Luo D; Ma X; Yang W; Xi Y; Wang H; Qian M; Fan L; Xia X; Li K; Wang D; Zhou J; Meng L; Wang S; Ma D
    J Control Release; 2012 Aug; 161(3):893-902. PubMed ID: 22580115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TMTP1, a novel tumor-homing peptide specifically targeting metastasis.
    Yang W; Luo D; Wang S; Wang R; Chen R; Liu Y; Zhu T; Ma X; Liu R; Xu G; Meng L; Lu Y; Zhou J; Ma D
    Clin Cancer Res; 2008 Sep; 14(17):5494-502. PubMed ID: 18765541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DT390-triTMTP1, a novel fusion protein of diphtheria toxin with tandem repeat TMTP1 peptide, preferentially targets metastatic tumors.
    Ma X; Lv P; Ye S; Zhang Y; Li S; Kan C; Fan L; Liu R; Luo D; Wang A; Yang W; Yang S; Bai X; Lu Y; Ma D; Xi L; Wang S
    Mol Pharm; 2013 Jan; 10(1):115-26. PubMed ID: 23198829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of (99m)Tc-HYNIC-TMTP1 as a tumor-homing imaging agent targeting metastasis with SPECT.
    Li F; Cheng T; Dong Q; Wei R; Zhang Z; Luo D; Ma X; Wang S; Gao Q; Ma D; Zhu X; Xi L
    Nucl Med Biol; 2015 Mar; 42(3):256-62. PubMed ID: 25516099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antitumor and antimetastatic effect of antimicrobial peptide conjugated with tumor homing peptide TMTP1 on the transplanted prostate cancer and gastric cancer in nude mice].
    Ma XY; Li S; Luo DF; Liu RH; Lu YP; Wang SX; Ma D; Xi L
    Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):737-41. PubMed ID: 24378093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel fusion protein sTRAIL-TMTP1 exhibits a targeted inhibition of primary tumors and metastases.
    Liu R; Ma X; Wang H; Xi Y; Qian M; Yang W; Luo D; Fan L; Xia X; Zhou J; Meng L; Wang S; Ma D; Xi L
    J Mol Med (Berl); 2014 Feb; 92(2):165-75. PubMed ID: 24158182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell Permeable NBD Peptide-Modified Liposomes by Hyaluronic Acid Coating for the Synergistic Targeted Therapy of Metastatic Inflammatory Breast Cancer.
    Sun Y; Li X; Zhang L; Liu X; Jiang B; Long Z; Jiang Y
    Mol Pharm; 2019 Mar; 16(3):1140-1155. PubMed ID: 30668131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of electronic-neutral penetrating peptides cyclosporin A to deliver pro-apoptotic peptide: A possibly better choice than positively charged TAT.
    Gao W; Yang X; Lin Z; He B; Mei D; Wang D; Zhang H; Zhang H; Dai W; Wang X; Zhang Q
    J Control Release; 2017 Sep; 261():174-186. PubMed ID: 28662902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced antitumor effects of the BRBP1 compound peptide BRBP1-TAT-KLA on human brain metastatic breast cancer.
    Fu B; Long W; Zhang Y; Zhang A; Miao F; Shen Y; Pan N; Gan G; Nie F; He Y; Zhang J; Teng G
    Sci Rep; 2015 Jan; 5():8029. PubMed ID: 25619721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of ErbB2-overexpressing breast cancer in vivo by a novel TAT-based ErbB2-targeting signal transducers and activators of transcription 3-blocking peptide.
    Tan M; Lan KH; Yao J; Lu CH; Sun M; Neal CL; Lu J; Yu D
    Cancer Res; 2006 Apr; 66(7):3764-72. PubMed ID: 16585203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metal-binding domain of IGFBP-3 selectively delivers therapeutic molecules into cancer cells.
    Huq A; Singh B; Meeker T; Mascarenhas D
    Anticancer Drugs; 2009 Jan; 20(1):21-31. PubMed ID: 19342998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TMTP1, a novel tumor-homing peptide, specifically targets hematological malignancies and their metastases.
    Xiao M; Hong Z; Sun L; Wu Y; Zhang N; Liu Y; Luo D; Zhou J; Li C
    J Huazhong Univ Sci Technolog Med Sci; 2011 Oct; 31(5):608. PubMed ID: 22038348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of a bi-functional dendrimer-based nanovehicle co-modified with RGDyC and TAT peptides for neovascular targeting and penetration.
    Li J; Zhang X; Wang M; Li X; Mu H; Wang A; Liu W; Li Y; Wu Z; Sun K
    Int J Pharm; 2016 Mar; 501(1-2):112-23. PubMed ID: 26828670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient induction of anti-tumor immunity by a TAT-CEA fusion protein vaccine with poly(I:C) in a murine colorectal tumor model.
    Park JS; Kim HS; Park HM; Kim CH; Kim TG
    Vaccine; 2011 Nov; 29(47):8642-8. PubMed ID: 21945963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-penetrating peptides and peptide nucleic acid-coupled MRI contrast agents: evaluation of cellular delivery and target binding.
    Mishra R; Su W; Pohmann R; Pfeuffer J; Sauer MG; Ugurbil K; Engelmann J
    Bioconjug Chem; 2009 Oct; 20(10):1860-8. PubMed ID: 19788302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumor effects of the peptide TMTP1-GG-D(KLAKLAK)(2) on highly metastatic cancers.
    Ma X; Xi L; Luo D; Liu R; Li S; Liu Y; Fan L; Ye S; Yang W; Yang S; Meng L; Zhou J; Wang S; Ma D
    PLoS One; 2012; 7(9):e42685. PubMed ID: 22984407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1.
    Hu M; Wang J; Chen P; Reilly RM
    Bioconjug Chem; 2006; 17(5):1280-7. PubMed ID: 16984139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting human epidermal growth factor receptor 2 by a cell-penetrating peptide-affibody bioconjugate.
    Govindarajan S; Sivakumar J; Garimidi P; Rangaraj N; Kumar JM; Rao NM; Gopal V
    Biomaterials; 2012 Mar; 33(8):2570-82. PubMed ID: 22192536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of a tumor metastasis targeting peptide to deliver doxorubicin-containing liposomes to highly metastatic cancer.
    Wang Z; Yu Y; Dai W; Lu J; Cui J; Wu H; Yuan L; Zhang H; Wang X; Wang J; Zhang X; Zhang Q
    Biomaterials; 2012 Nov; 33(33):8451-60. PubMed ID: 22940213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of RasGAP N2 fragment-derived peptide on tumor growth in mice.
    Michod D; Annibaldi A; Schaefer S; Dapples C; Rochat B; Widmann C
    J Natl Cancer Inst; 2009 Jun; 101(11):828-32. PubMed ID: 19470951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.